Moderna gets USFDA Breakthrough Therapy Designation for RSV vaccine Ruchika Sharma1 Feb 2023 4:00 PM ISTmRNA-1345 is an investigational RSV vaccine that consists of a single mRNA sequence encoding for a stabilized prefusion F glycoprotein.
Pfizer secures USFDA priority review for RSV vaccine for older adults Ruchika Sharma8 Dec 2022 3:00 PM ISTRSV is a contagious virus and a common cause of respiratory illness.
Sanofi gets European Commission nod for Beyfortus to prevent RSV disease in infants Ruchika Sharma5 Nov 2022 3:00 PM ISTRSV is the most common cause of LRTI, including bronchiolitis and pneumonia, in infants.
GSK gets USFDA priority review for RSV older adult vaccine Ruchika Sharma4 Nov 2022 12:15 PM ISTGSK’s RSV older adult vaccine candidate contains a recombinant subunit prefusion RSV F glycoprotein antigen (RSVPreF3) combined with GSK’s proprietary...
GSK marketing authorisation application for RSV older adult vaccine accepted by EMA under accelerated assessment Ruchika Sharma31 Oct 2022 3:44 PM ISTRespiratory Syncytial Virus is a common contagious virus affecting the lungs and breathing passages.
GSK RSV vaccine for older adults under Japanese regulator review Ruchika Sharma23 Oct 2022 11:53 AM ISTRSV is a common contagious virus affecting the lungs and breathing passages.
Maternal administration of RSVpreF Vaccine Prevents RSV Infection in Infants: NEJM MD Bureau28 April 2022 9:30 AM ISTRespiratory syncytial virus (RSV), a major cause of illness and death in infants worldwide, could be prevented by vaccination during pregnancy. A...
Pfizer to purchase ReViral for Rs 3984 crore Ruchika Sharma10 April 2022 10:00 AM ISTIf successful, Pfizer believes annual revenue for these programs has the potential to reach or exceed USD 1.5 billion.
Adults with CHF at increased risk of hospitalization due to respiratory syncytial virus Medha Baranwal17 March 2022 9:00 AM ISTUSA: Adults with congestive heart failure (CHF) are at an 8-fold increased risk of respiratory syncytial virus (RSV)-associated hospitalization versus...
GSK halts respiratory virus vaccine trial in pregnant women Ruchika Sharma19 Feb 2022 2:16 PM ISTLondon: GSK has paused a late-stage trial of its vaccine candidate against the respiratory syncytial virus (RSV) in pregnant women based on safety...
Pfizer begins Phase 3 trial of RSV vaccine in adults Ruchika Sharma5 Sept 2021 10:00 AM ISTNew York: Pfizer Inc. has recently announced the initiation of RENOIR (RSV vaccine Efficacy study iN Older adults Immunized against RSV disease), a...
Johnson and Johnson Rilematovir gets CDSCO panel okay for phase 3 trial Medical Dialogues Team18 Aug 2021 4:18 PM ISTNew Delhi: Global pharmaceuticals major Johnson and Johnson (JnJ) has got a go ahead from the Subject Expert Committee (SEC) of the Central Drugs...
